In addition, CBX7 was not expressed in > 90% (11 of 12) of patients who had died of the tumor (median survival time: 40 months), but was not expressed in only 55% (11 of 20) of patients with no tumor specific death (median survival time: 75 months) (p = 0.03, Pearson Chi2 test, two-sided). This evidence concerns the gene CBX7 and neoplasm.